EGFR, HER2 and HER3 dimerization patterns guide targeted inhibition in two histotypes of esophageal cancer

Author:

Fichter Christiane Daniela12,Timme Sylvia1,Braun Julia Alexandra1,Gudernatsch Verena1,Schöpflin Anja1,Bogatyreva Lioudmilla3,Geddert Helene4,Faller Gerhard4,Klimstra David5,Tang Laura5,Hauschke Dieter3,Werner Martin167,Lassmann Silke1678

Affiliation:

1. Department of Pathology; University Medical Center; Freiburg Germany

2. Faculty of Biology; University of Freiburg; Freiburg Germany

3. Institute of Medical Biometry and Medical Informatics, University Medical Center; Freiburg Germany

4. Department of Pathology; St. Vincentius-Kliniken; Karlsruhe Germany

5. Department of Pathology; Memorial Sloan-Kettering Cancer Center; New York NY USA

6. Comprehensive Cancer Center Freiburg; University Medical Center; Freiburg Germany

7. German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ); Heidelberg Germany

8. BIOSS Centre for Biological Signalling Studies; University of Freiburg; Freiburg Germany

Funder

Deutsche Forschungsgemeinschaft

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference49 articles.

1. Untangling the ErbB signalling network;Yarden;Nat Rev Mol Cell Biol,2001

2. Comparing antibody and small-molecule therapies for cancer;Imai;Nat Rev Cancer,2006

3. Predictive pathology in routine diagnostics of solid tumors;Lassmann;Histol Histopathol,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3